The effectiveness of the peer delivered Thinking Healthy Plus (THPP+) Programme for maternal depression and child socio-emotional development in Pakistan: study protocol for a three-year cluster randomized controlled trial by Elizabeth L. Turner et al.
STUDY PROTOCOL Open Access
The effectiveness of the peer delivered
Thinking Healthy Plus (THPP+) Programme
for maternal depression and child socio-
emotional development in Pakistan: study
protocol for a three-year cluster
randomized controlled trial
Elizabeth L. Turner1,2, Siham Sikander3, Omer Bangash3, Ahmed Zaidi3, Lisa Bates4, John Gallis1,2, Nima Ganga1,
Karen O’Donnell1, Atif Rahman5* and Joanna Maselko6*
Abstract
Background: The negative effects of perinatal depression on the mother and child start early and persist
throughout the lifecourse (Lancet 369(9556):145–57, 2007; Am J Psychiatry 159(1):43-7, 2002; Arch Dis Child 77(2):
99–101, 1997; J Pak Med Assoc 60(4):329; J Psychosoma Res 49(3):207–16, 2000; Clin Child Fam Psychol Rev 14(1):
1–27, 2011). Given that 10–35% of children worldwide are exposed to perinatal depression in their first year of life
(Int Rev Psychiatry 8(1):37–54, 1996), mitigating this intergenerational risk is a global public health priority (Perspect
Public Health 129(5):221–7, 2009; Trop Med Int Health 13(4):579–83, 2008; Br Med Bull 101(1):57–79, 2012). However,
it is not clear whether intervention with depressed women can have long-term benefits for the mother and/or her
child. We describe a study of the effectiveness of a peer-delivered depression intervention delivered through 36 postnatal
months, the Thinking Healthy Program Peer-delivered PLUS (THPP+) for women and their children in rural Pakistan.
Methods/design: The THPP+ study aims are: (1) to evaluate the effects of an extended 36-month perinatal depression
intervention on maternal and index child outcomes using a cluster randomized controlled trial (c-RCT) and (2) to
determine whether outcomes among index children of perinatally depressed women in the intervention arm converge
with those of index children born to perinatally nondepressed women. The trial is designed to recruit 560 pregnant
women who screened positive for perinatal depression (PHQ-9 score ≥10) from 40 village clusters, of which 20 receive
the THPP+ intervention. An additional reference group consists of 560 perinatally nondepressed women from the same
40 clusters as the THPP+ trial. The women in the nondepressed group are not targeted to receive the THPP+
intervention; but, by recruiting pregnant women from both intervention and control clusters, we are able to evaluate
any carryover effects of the THPP+ intervention on the women and their children. Perinatally depressed women in the
THPP+ intervention arm receive bimonthly group-based sessions. Primary outcomes are 3-year maternal depression
and 3-year child development indicators. Analyses are intention-to-treat and account for the clustered design.
(Continued on next page)
* Correspondence: atif.rahman@liverpool.ac.uk; jmaselko@unc.edu
5Institute of Psychology, Health and Society, University of Liverpool,
Liverpool, UK
6Department of Epidemiology, Gillings School of Public Health, University of
North Carolina Chapel Hill, Chapel Hill, USA
Full list of author information is available at the end of the article
© Turner et al. 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Turner et al. Trials  (2016) 17:442 
DOI 10.1186/s13063-016-1530-y
(Continued from previous page)
Discussion: This trial, together with the reference group, has the potential to further our understanding of the early
developmental lifecourse of children of both perinatally depressed and perinatally nondepressed women in rural
Pakistan and to determine whether intervening with women’s depression in the perinatal period can mitigate the
negative effects of maternal depression on 36-month child development.
Trial registration: THPP-P ClinicalTrials.gov Identifier: NCT02111915 (registered on 9 April 2014).
THPP+ ClinicalTrials.gov Identifier: NCT02658994 (registered on 21 January 2016).
Sponsor: Human Development Research Foundation (HDRF).
Keywords: Thinking healthy program, Psychological treatment, Peer volunteers, Nonmental health professionals,
Perinatal depression, Maternal depression, Task-shifting, Randomized trials, Low- and middle-income countries, Child
development
Background
Perinatal maternal depression, defined by at least one
depressive episode during pregnancy and/or the first
postnatal year, has been shown to have negative
health effects for both the mother and the child.
Negative effects on the mother include reductions in
daily functioning as well as early mortality. Negative
effects on the child, including illness and poor
growth, start early and persist throughout the child’s
life [1–6]. Given that 10–35% of children worldwide
are exposed to perinatal depression in their first year
[7], mitigating this intergenerational risk is a global
public health priority [8–10]. Pakistan has one of the
highest rates of maternal depression globally, and one
of the only studies examining potential long-term
benefits of maternal depression interventions on child
outcomes found no significant effects [11].
The Thinking Health Program (THP), a community
health worker (CHW)-delivered intervention developed
and evaluated in Pakistan, was shown to have beneficial
effects on both perinatal maternal depression and short-
term child outcomes including reductions in diarrheal
episodes and increased vaccination rates [12]. In 2015,
the THP was formally designated by the World Health
Organization (WHO) as an evidence-based intervention
that could be implemented in a variety of global settings
using an established CHW healthcare delivery system
[13]. Unfortunately, many CHW systems, such as
Pakistan’s, are underfunded and stretched to capacity;
and alternative delivery methods are required. In re-
sponse to this need, the Thinking Health Program Peer-
delivered (THPP) was developed by adapting the THP to
be delivered primarily by peers who operate within the
existing CHW system. An ongoing study, the THPP-
Pakistan trial [14], seeks to evaluate THPP for 6 postna-
tal months.
Although effective in reducing maternal perinatal depres-
sion, our recent work failed to show that the 6-month
CHW-led THP led to improved longer-term child out-
comes [11]. At age 7 years, children of perinatally depressed
mothers who received the intervention did not show better
outcomes than children of control group mothers. To im-
prove the longer-term outcomes of both perinatally de-
pressed mothers and their children, we have developed the
Thinking Health Program Peer-delivered PLUS (THPP+),
an extension of the 6-month THPP intervention delivered
at a lower intensity for an additional 30 postnatal months
to the same women who have been receiving the THPP.
The THPP+ is an extension and a continuation of the
THPP intervention for mothers until the child is 3 years
old.
The aim of this manuscript is to describe the proto-
col for the THPP+ study in Pakistan. The THPP+
study is a cluster randomized controlled trial (c-RCT),
which compares outcomes among three groups of
mother-child dyads: (1) those receiving the interven-
tion, (2) those receiving Enhanced Usual Care (EUC)
in the control clusters, and (3) a reference group of
mother-child dyads in which the woman was not de-
pressed in pregnancy and resides in the same inter-
vention and control clusters where the trial is being
implemented. Focusing on outcomes at 36 postnatal
months, the goal of this c-RCT is to evaluate the cu-
mulative effectiveness of the combined THPP and
THPP+ interventions on mothers and their children.
The goal of the embedded reference group of peri-
natally nondepressed women and their children is
two-fold: (1) to evaluate whether the intervention is
able to meaningfully reduce the gap in child out-
comes that is traditionally observed when comparing
children of depressed and nondepressed mothers; and
(2) to determine whether there are any beneficial car-
ryover effects of the intervention on this nonde-
pressed group.
This manuscript complements and extends the THPP
trial protocol [14]. To ensure that the current protocol
is able to stand alone, we present the necessary key fea-
tures of the THPP design and the ways in which the
THPP+ trial builds on, and is different from, the on-
going THPP trial in Pakistan.
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Objectives and hypotheses
The primary objective of the study is to evaluate the im-
pact of a 36-month perinatal peer-delivered community-
based perinatal depression intervention on (1) maternal
depression and (2) child development. Our primary hy-
pothesis for the perinatally depressed mothers is that the
intervention will result in lower prevalence of depression
at 3 years postnatal. Our primary hypothesis for the chil-
dren is that the perinatal depression intervention will
lead to improved developmental outcomes (see “Mea-
sures and constructs” in Table 1) at 3 years of age. Add-
itional child hypotheses address proposed mediators and
moderators of the effects of the perinatal depression
intervention on child outcomes.
The second objective is to determine whether out-
comes of perinatally depressed mothers and children in
the intervention arm will converge to those in the refer-
ence group of perinatally nondepressed mothers and
children as well as, secondarily, to determine whether
there are any carryover effects of the intervention to
benefit perinatally nondepressed mothers and children.
Methods/design
Trial settings
The study will be conducted in rural Pakistan in the
rural Sub-District of Kallar Syedan, Rawalpindi, Pakistan.
Design
The THPP+ trial is a stratified cluster randomized con-
trolled trial (c-RCT) of 40 village clusters allocated in a 1:1
ratio to receive intervention or EUC within 11 strata de-
fined by Union Councils (sub-district units), each with an
even number of village clusters [15]. Cluster randomization
is used to avoid contamination between women since the
THPP intervention is delivered at the community level
through CHWs and peer women in the community. Strati-
fication is used to minimize imbalance in baseline
covariates.
THPP+ is conducted in the same 40 village clusters as
the THPP trial. The same study population of perinatally
depressed women is invited to consent to participate in
THPP+. An equal number of perinatally nondepressed
women are also recruited from each village cluster. The
latter forms the reference group that enables us to evalu-
ate whether convergence of maternal and child out-
comes occurs during the 3-year postnatal period. In
summary, all depressed women enrolled in the THPP+
trial were enrolled in THPP, while all nondepressed
women are only recruited to the THPP+ study. See Fig. 1
for details of the distinction.
In brief, the ongoing THPP trial focuses on the effects
of the THPP intervention on maternal outcomes at 6
postnatal months, with a limited number of child out-
comes measured. The THPP+ protocol is designed to re-
cruit the same 560 pregnant women who screen positive
for perinatal depression from the 40 village clusters de-
scribed above for the THPP trial, of which 20 clusters re-
ceive the THPP intervention delivered by trained lay
peer volunteers.
Participants and procedures
Figures 1 and 2 show recruitment and flow of both
the perinatally depressed and perinatally nondepressed
mother-child dyads through the study. After collecting
prebirth baseline information, we assess each mother
and her index child born during the study at 3, 6, 12,
24 and 36 postnatal months. The 3- and 6-month as-
sessments will coincide with those of the THPP trial.
The 12-, 24- and 36-month assessments are unique
to THPP+ (further details in Additional file 1).
Recruitment of study participants: inclusion and exclusion
criteria
The current THPP+ study consists of perinatally de-
pressed women and the index children who are partici-
pating in the THPP study and an additional sample of
nonperinatally depressed mothers and of the index child
Table 1 Primary outcome measures for women and children in the Thinking Health Program Peer-delivered PLUS (THPP+)
Source of data Postnatal months
Outcomes Measure 3 6 12 24 36
Mother: depression Patient Health Questionnaire (PHQ-9) ✓ ✓ ✓
WHO Disability Assessment Schedule (WHO-DAS) ✓ ✓ ✓
Child: socioemotional Total Difficulties score from the Strengths and Difficulties Questionnaire (SDQ-TD) ✓
Ages and Stages Questionnaire (ASQ) ✓ ✓ ✓ ✓
Child: developmental milestones Bayley Scales of Infant and Toddler Development III (BSITD-III) ✓ ✓ ✓
Child: physical Length, weight (WHO weight-for-length z-scores) ✓ ✓ ✓ ✓ ✓
Head circumference ✓ ✓ ✓ ✓ ✓
Diarrhea/ARI ✓ ✓ ✓ ✓
ARI acute respiratory infection, WHO World Health Organization
Turner et al. Trials  (2016) 17:442 Page 3 of 11
of each mother. For THPP, pregnant women registered
with the CHW (called Lady Health Workers) were
approached. The study team has been engaged with the
Lady Health Workers and the community in the past and
enrollment rates have been consistently high. All eligible
women in their third trimester of pregnancy were assessed
for depression using the Patient Health Questionnaire
(PHQ-9) and those scoring above the 10-point cutoff were
invited to participate in the trial. For THPP, a random
sample of approximately a third of women scoring less
than 10 (i.e., screening negative on PHQ-9) are asked to
serve as an additional reference group of equal size as the
number of perinatally depressed women. In order to be
eligible to participate, women need to be married, to res-
ide in the study area, to understand one of the study lan-
guages (Urdu, Punjabi or Potohari), and to not require
immediate medical attention. Following a live birth, the
mother-infant dyads remain eligible to continue in the
study unless the woman develops a psychotic or manic
episode, or the dyad is broken through death, disability or
relocation of the woman or child. Any participant who de-
velops severe symptoms over the course of the study will
be immediately referred for additional treatment.
Informed consent
Women are informed about the study goals and study
design in the third trimester of pregnancy by trained re-
search staff. Those who agree to participate consent to
be followed up for 3 years postnatally and to participate
in an intervention if they screen positive for perinatal
depression. This consent covers the THPP+ period. The
additional THPP+ sessions are seamlessly added to the
existing intervention content for depressed women in
the intervention clusters.
Randomization
The current THPP+ study is designed to maintain the
randomization that was performed at the start of the
THPP. According to the randomization procedure, 11
UC strata were selected with an even number of village
clusters identified in each. Within each UC, village clus-
ters were then randomized in a 1:1 ratio. In total, there
are 20 intervention and 20 control arm clusters.
Interventions
Thinking Healthy Program Peer-delivered (THPP)
The Thinking Healthy Program Peer-delivered (THPP)
is an adaptation of the Lady Health Worker-delivered
THP, that was adopted by the WHO mhGAP Series [13].
The protocol for the THPP trial has been published [14].
Similar in content to the THP, the peer-delivered version
is simplified with additional strategies added for ease of
implementation by peers. The intervention focuses on
identifying and altering unhealthy behaviors with a focus
on behavioral activation to facilitate change. It consists
of both individual sessions with the peers as well as
Fig. 1 THPP+ study (both the trial of perinatally depressed mothers and the reference group of perinatally nondepressed mothers) in relation to
the THPP intervention trial showing anticipated loss to follow-up. N = number of mother-child dyads. Unshaded area is unique to the
THPP+ study
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group sessions held at the “Health House,” a room in
the home of the CHW dedicated for women’s group
meetings. The THPP begins in the third trimester of
pregnancy and finishes at the end of the sixth postnatal
month.
Thinking Healthy Program Peer-delivered PLUS (THPP+)
As part of THPP+, the intervention continues from the
beginning of the seventh postnatal month through the
end of the 36th month, and consists of an additional
30 months of lower-intensity services unique to the
THPP+ model. We use the term THPP+ to refer to the
combined 6-month THPP intervention and the 30-
month THPP+ intervention delivered consecutively
through 36 months after the index child’s birth. The
THPP+ includes group sessions to be held roughly every
other month for a total of 18 sessions over the interven-
tion duration. The content is a continuation of the pre-
vious THPP sessions with emphasis on self-care and on
the baby’s health and development. In order to ensure
continued participation, peers contact each woman a
week prior to the group session and the groups are held
in the community where the participants live and are
easily accessible. Peers keep session logs which are over-
seen by the peer supervisors and can be used for calcula-
tion of “dose” during analyses.
Fig. 2 Flow chart of the THPP+ study
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In case a woman misses attending a session the peer
follows up at the household to work out/negotiate with
the family to ensure attendance at the next session (so that
the “dose” is not missed).
Although the perinatally nondepressed women in the
intervention arm do not receive the THPP+ interven-
tion, by recruiting mothers from both intervention and
control clusters, we are able to evaluate any effects of
the THPP+ on the group that is not directly targeted.
Enhanced Usual Care
Women in the control clusters who were depressed pre-
natally have been receiving Enhanced Usual Care (EUC).
At the time of the screening (and with consent), women,
their Lady Health Workers and personnel in their local
primary health care facility were informed of the diagno-
sis; and women were given an information sheet about
depression and how to access care. There are no new
EUC protocols put in place postnatally as part of the
THPP+.
Additional training and supervision of peers
For the THPP, peers were trained in a 5-day classroom-
based workshop, followed by a 2-month internship dur-
ing which they practiced the content of the THPP on
nontrial participants [14]. For THPP+, peers will receive
an additional 2 days of classroom training after their last
session (during the fifth postnatal month) of the THPP
to cover the additional content. Competency is assessed
by role plays. Peer counselors continue to receive
monthly group supervision to maintain high motivation
and to address any challenges in the field.
Minimization of contamination
Risk of new contamination between the treatment and
control arms is expected to be very low given the low in-
tensity of the intervention and its placement after the
end of the more intensive intervention that began pre-
natally and lasted through to 6 postnatal months. The
cluster design makes it less likely that women will ex-
change information related to the intervention.
Masking of treatment allocation
Although it is not possible to blind study participants
from their treatment arm allocation, all project staff, in-
cluding interviewers, are blind both to a woman’s ori-
ginal depression status and to the treatment arm of the
village cluster in which she resides. Study participants
are instructed to not discuss their depression status or
intervention (or lack thereof ) with the assessors. The
data linking each village cluster with treatment alloca-
tion status is kept separate from the remaining outcome
dataset until the time of the final analysis.
Fidelity of the intervention
Fidelity of the intervention is assessed through docu-
menting the number of women who attend the meetings
in combination with documenting the content covered
during the meetings and the duration of each compo-
nent covered in the session.
Data management
All data capture is performed electronically on tablets
and uploaded daily to the main server. Quality checks
for consistency, accuracy, missing data and other irregu-
larities are conducted weekly. Any issues are shared with
the research team and discussed during a weekly staff
meeting to address source of any problems in the field.
Data are backed up daily. Data are deidentified/anon-
ymized before being shared with coinvestigators outside
of the Human Development Research Foundation
(HDRF). At all stages, data are password-protected with
multiple layers of authorization.
Outcome evaluation
The primary endpoint is designed to be at 3 years post-
natally. The primary comparison tested is between peri-
natally depressed-intervention versus perinatally
depressed-control women in order to evaluate the effect-
iveness of the THPP+ intervention on long-term out-
comes in perinatally depressed mothers and their
children born during the intervention period (i.e., “index
child”). Secondary comparisons for mothers and their
index children are (1) intervention perinatally depressed
mothers versus control perinatally nondepressed
mothers to assess convergence of outcomes in both
mothers and children and (2) intervention perinatally
nondepressed versus control perinatally nondepressed
mothers to assess whether there are any carryover effects
of the intervention that benefit perinatally nondepressed
mothers and their index children. For the former, the
statistical goal is to demonstrate equivalence of out-
comes of control perinatally nondepressed and interven-
tion perinatally depressed mothers and their children.
For the latter, the goal is to test the null hypothesis of
no difference between groups in the outcomes of inter-
est. The mother and child outcome measures are de-
tailed in Tables 1 and 2.
Mother outcome measure
Patient Health Questionnaire (PHQ-9)
The PHQ-9 is the main indicator of depression symp-
toms among the women in the study. The PHQ-9 in-
quires about frequency of depressive symptoms in the
last 2 weeks. It has been validated and used extensively
in the region [16, 17].
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WHO Disability Assessment Schedule (WHO-DAS)
The WHO-DAS is a 12-item questionnaire assessing
levels of function over the last 30 days. Combined with
two items about one’s ability to work in the last 30 days,
the WHO-DAS generates a total disability score, quality-
adjusted life years and number of days the respondent is
not able to work [18].
Child outcome measures
Socioemotional development
Our main outcome measure is the Total Difficulties
(TD) score derived from the Strengths and Difficulties
Questionnaire (SDQ). The SDQ is a parent report of 25
child attributes divided into five subscales: emotional
symptoms, conduct problems, hyperactivity, peer prob-
lems and prosocial behavior [19]. The TD score is calcu-
lated based on four subscales (except prosocial behavior)
with a score range of 0–40 points [20]. The SDQ has
previously been translated into Urdu as well as at least
50 other languages and used in low- and middle-income
countries [21–23].
ASQ
Socioemotional developmental milestones, prior to and in-
cluding 36 months, are assessed with the Ages and Stages
Questionnaire Socio-Emotional scale (ASQ-SE) [24, 25].
The ASQ is a widely used, simple set of 25 questions where
parents are asked to report age-appropriate milestones
with the help of simple examiner-administered examples,
such as whether, at 8 months, the child plays with a toy by
banging it up or down on the floor or table [26].
Infant developmental milestone achievement
Bayley Scales of Infant Development The Bayley
Scales of Infant and Toddler Development, Third Edi-
tion (BSID-III) is an individually administered assess-
ment of the child’s achievement of developmental
milestones across five areas: cognitive, language, motor,
social-emotional and adaptive skills [27]. The evaluations
are conducted in the family’s home at infant ages 12, 24
and 36 months. Raw scores in each domain are summa-
rized by chronological age-related scaled scores and
composite scores for each domain. The standard scores
are derived from the US norms; and, because there are
no available Pakistani norms, the scores provide a metric
with which to compare groups of children in this
Pakistan setting relative to the study hypotheses. The
evaluators were trained in administration of the BSID-III
by the team clinical psychologist (O’Donnell, US-based)
and by the local team, which includes a psychiatrist and
a physician. Periodic quality assurance is assessed at
least quarterly by dyadic testing (evaluator plus team
psychologist) and by double scoring by the US-based
psychologist.
Physical development
Physical development is assessed using weight-for-age
and height-for-age. Weight-for-age is sensitive to weight
change over a short time period but fails to distinguish
Table 2 Outcome assessments
Instrument Description Outcome Contextual validity
PHQ-9 Nine-item questionnaire assessment of
depressive symptoms assessed on a scale of 0
to 3
Prevalence of moderate–severe
depression; mean total score
Validated in primary care [37]
WHO-DAS 12-item questionnaire for measuring
functional impairment over the last 30 days. In
addition, two items assess the number of days
the person was unable to work in these
30 days
Total disability score; quality-adjusted
life years; number of days out of work
Validated for international use [18]
SDQ-TD The SDQ is a parent report of 25 child
attributes divided into five subscales:
emotional symptoms, conduct problems,
hyperactivity, peer problems and prosocial
behavior
Total Difficulties score: calculated based
on four subscales (except prosocial
behavior)
The SDQ has previously been translated into
Urdu as well as at least 50 other languages
and used in low- and middle-income countries
[21–23]
ASQ The ASQ is a widely used, simple set of 30
questions appropriate for 4–60 month-olds
that assesses five domains of development
The total score from the five domains,
plus the score from an additional
domain on the child’s socioemotional
development
The parent-report-based ASQ assessments
have been shown to have good concurrent
validity with professionally administered BSITD
[24, 38], including internationally [39, 40]
BSITD-III An individually administered assessment of
the child’s achievement of developmental
milestones across five areas: cognitive,
language, motor, social-emotional and adaptive
skills [27]
The total score from each domain The standard scores are derived from the US
norms; and, because there are no available
Pakistani norms, the scores provide a metric
with which to compare groups of children in
this Pakistan setting relative to the study
hypotheses
ASQ Ages and Stages Questionnaire Socio-Emotional scale, BSITD-III Bayley Scales of Infant and Toddler Development, Third Edition, PHQ Patient Health
Questionnaire, SDQ-TD Strengths and Difficulties Questionnaire, WHO-DAS WHO Disability Assessment Schedule
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tall, thin children from those who are short with ad-
equate weight. Height-for-age is useful for identifying
children with short stature, a group often vulnerable to
longer-term adverse conditions. Based on WHO norms,
a measure of 2 standard deviations (SD) below the mean
of either weight or height is chosen to indicate poor
growth. Head circumference is measured through
24 months. Physical health indicators are recent diar-
rheal episodes and acute respiratory infections.
Power calculations
The primary power calculations for the THPP+ study
are for the c-RCT comparisons of perinatally depressed
women and their children in the control versus interven-
tion arms at 36 postnatal months at the 5% two-tailed
significance level. As for the THPP trial [14] we assume
40 village clusters randomized in a 1:1 allocation ratio
within 11 UCs, with 14 perinatally depressed women per
village cluster, to yield a total sample size of 560 peri-
natally depressed women at baseline. In addition, for
THPP+ we recruit 14 perinatally nondepressed women
per village cluster for a total of 560 perinatally nonde-
pressed women at baseline. We conservatively estimate
that loss to follow-up (including infant mortality and
maternal illness and death) of both perinatally depressed
and perinatally nondepressed women at 36 months will
be 20% (anticipated loss to follow-up in the THP trial
was 10% at 6 months and most loss to follow-up is ex-
pected in the first 6 months of the study) [12]. There-
fore, the total sample size available at 36 months is
anticipated to be 480 perinatally depressed and 480 peri-
natally nondepressed women and their children. Using a
standard formula [28, 29] for a cluster randomized de-
sign and assuming an intracluster correlation of 0.07 in
the intervention arm and 0.05 in the control arm, the
trial will have 90% power at 36 months to detect a dif-
ference in perinatally depressed remission of 65% in the
perinatally depressed-intervention versus 45% in the
perinatally depressed-control for the anticipated total
sample size of 480 perinatally depressed women at
36 months. For child outcomes, this sample size will yield
power of more than 90% to detect a difference between
arms in mean TD score (range 0–40) of 3 points for chil-
dren of perinatally depressed mothers using plausible esti-
mates for intracluster correlations of 0.04–0.08 [12], and
5.2 for SD for the TD score among 3 year-olds [30].
Secondary comparisons mainly focus on child out-
comes and are well-powered. For the secondary hypoth-
esis of equivalence between children of perinatally
depressed mothers in the intervention arm and peri-
natally nondepressed mothers in the control arm, we
will conclude equivalence if the 95% confidence interval
(CI) for the difference between the mean score in the
two groups lies between −2 and 2 units. We note that
differences of 1.0–2.0 points are often observed between
boys and girls [30, 31]. With 220 children in each group
and conservatively assuming an overall significance level
of 2.5% (corresponding to the 95% CI), an SD of 5.2
and an ICC of 0.04, and no difference between the
groups, we will have 83% power to conclude equiva-
lence [28, 32]. For the secondary research question of
the community benefit (i.e., carryover) of the interven-
tion for perinatally nondepressed women and their chil-
dren, we will have 80% power to detect a 1.7 or greater
impact of the intervention on mean TD score (groups:
perinatally nondepressed-intervention versus perinatally
nondepressed-control, Fig. 1) for the same assumptions of
the primary comparison above.
Analysis
Statistical analysis will be conducted according to the
Consolidated Standards of Reporting Trials (CONSORT)
guidelines. A flow chart will show participation of both
perinatally depressed and perinatally nondepressed
mothers and their children from recruitment in the third
trimester through to 36 postnatal months (Fig. 2). With-
drawals and loss to follow-up will be shown at each
follow-up (3, 6, 12, 24 and 36 postnatal months). Base-
line characteristics of recruited mothers will be reported
by study arm, and separately for perinatally depressed
and perinatally nondepressed mothers. Continuous vari-
ables will be summarized by means and standard devi-
ation (SD), or medians and the 25th and 75th percentile,
if needed. Categorical variables will be summarized by
counts and percentages.
The primary analyses are designed as intention-to-
treat and will be conducted using the latest release of
Stata software. Separate outcome analysis will be con-
ducted for mothers and for children. In both cases, data
from perinatally depressed and perinatally nondepressed
participants will be analyzed jointly using generalized
linear mixed-effects models so that all comparisons of
interest can be estimated from the same model. The
identity link will be used for continuous outcomes in
order to estimate differences in mean outcomes. The
log-link will be used for binary outcomes in order to es-
timate prevalence ratios, but if convergence is not
achieved we will use the logit link from which preva-
lence ratios will be estimated. Random intercepts for
cluster will be included to account for the clustered
study design. For outcomes measured at multiple follow-
up time points (e.g., for depression status in both peri-
natally depressed and perinatally nondepressed mothers,
which will be evaluated at all five follow-up time points),
random intercepts for person will be added to account
for correlation of repeated measures on person. Simi-
larly, in this case, random slopes for both cluster and
participant will be considered to allow for heterogeneity
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by cluster and participant over time. All random error
terms will be assumed independent and zero-mean nor-
mally distributed.
Primary analyses of outcomes measured at a single
follow-up time point are designed to include the follow-
ing fixed-factor variables: arm (intervention versus con-
trol), strata (11 Union Councils), baseline depression
status (perinatally depressed versus perinatally nonde-
pressed) and its interaction with arm. For outcomes
measured at multiple follow-up time points, the interac-
tions between study arm, follow-up time point and base-
line depression status will be included to allow for
different intervention effects at each follow-up time
point. Estimates of the prespecified comparisons of
interest will be derived from the fitted model. Conclu-
sions about the equivalence of perinatally depressed-
intervention and perinatally nondepressed-control will
be based on whether the corresponding 95% CI is con-
tained within the equivalence margins (i.e., −2 to 2 for
the primary child outcome of the TD score). Model as-
sumptions will be assessed; in the case of non-normally
distributed residuals, we will consider bootstrapping or
transformations to obtain valid CIs.
Secondary analyses will include any baseline covariates
for which there was chance baseline imbalance and for
any additional baseline covariates that predict missing
outcome data. Under the assumption that those covari-
ates explain the missing data mechanism, we will obtain
valid estimates of the intervention effects using the
complete case data (i.e., without the need for imputation
or an alternative method) [33]. If there are concerns or
evidence that covariates cannot explain the nature of the
missingness (i.e., if the data are missing not at random),
we will perform a series of sensitivity analyses based on
the pattern mixture approach [34].
Moderator and mediator analyses
In addition to our main outcomes, auxiliary analyses
focus on potential moderators and mediators of any
main associations. A-priori variables that might impact
the degree to which the intervention affects depression
symptoms include socioeconomic status, household
composition, and the presence of interpersonal violence.
These associations will be examined by including an
interaction between the variable of interest and the
intervention indicator in the primary outcome model.
Potential mediators of interest include maternal respon-
siveness, the mother-child relationship and social
support.
Compliance analysis
We plan to gather information on compliance with the
intervention and evaluate whether there is any evidence
of contamination between treatment arms.
Trial management
Trial monitoring procedures are a continuation of pro-
cedures and infrastructure in place for the THPP. This
includes oversight by two committees: the Trial Manage-
ment Committee (TMC), which is charged with close
monitoring of all aspects of the trial and its progress and
the Trial Steering Committee (TSC), which will provide
additional guidance on the overall trial protocols as well
as oversee trial safety issues. The TMC is composed of
the principal investigators and the site team (project dir-
ector, data manager/trial manager, local outcome assess-
ment trainer); it meets weekly. The TSC is composed of
the principal investigators, study coinvestigators, the trial
manager and the study statistician; the TSC will meet
every 6 months.
Ethical considerations
We protect the confidentiality of personal data princi-
pally through procedures to separate study data and par-
ticipant identifiable data. Quantitative data gathered
with the tablets for each participant at baseline retain
personal identification items to minimize errors in tran-
scribing identities, but these will be removed before
transferring the data to Stata for analysis. We monitor
the occurrence of a number of specific serious adverse
events (SAEs) beyond the THPP trial (among the de-
pressed cases); these include death of the participant or
her child due to any cause, suicide attempt, hospital ad-
mission due to a psychiatric problem, and hospital ad-
mission of participant or infant due to a serious medical
emergency. Their detection and appropriate response
(involving an independent psychiatrist responding) will
be reported to the local Ethics Committee. These SAEs
are compiled by the data manager and a blinded sum-
mary report is shared with the principal investigators
and the TSC.
Discussion
This trial and the parallel reference group of perinatally
nondepressed women have the potential to further our
understanding of the early developmental lifecourse of
children of both women who were, and were not, peri-
natally depressed and to evaluate whether intervening on
mothers’ perinatal depression can mitigate the negative ef-
fects of maternal depression on child development at
36 months. By beginning our study in the third trimester
of pregnancy and following the mother-child dyads with
multiple assessments through 36 postnatal months we will
be able to analyze the relationship between changes in
maternal depressive symptoms and child outcomes. For
example, we will be able to analyze the impact of early ver-
sus late remission; remission of symptoms followed by re-
currence; and new onset of symptoms on child outcomes.
With the 3 years of follow-up with multiple assessments,
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we will be able to undertake an analysis of potential time-
varying mechanisms.
By also enrolling a group of women who were peri-
natally nondepressed we are additionally be able to ad-
dress two substantive questions. The first is: How much
of the risk due to maternal depression exposure can the
intervention mitigate? We ultimately want to know
whether the intervention can prevent the intergenera-
tional transmission of negative mental health outcomes.
The children of prenatally depressed mothers in both
intervention and control arms of the THPP+ interven-
tion study are at high risk for multiple adverse out-
comes. We expect that, at the end of the study, the
children in the intervention arm will be at lower risk.
However, the full impact of the intervention can only be
discerned if we know the level of risk remaining – that
is, the difference between the reduced level of risk
among children (of prenatally depressed mothers) in the
intervention arm and the risk among children whose
mothers were not depressed to begin with. If outcomes
of these two groups are comparable, we can infer that
the intervention may prevent the intergenerational
transmission of risk. Unlike in high-income country set-
tings, normative data for such a comparison does not
exist in many low-resource areas, including Pakistan;
hence, the enrollment of nondepressed women [35, 36].
The second substantive question is: Does the interven-
tion have an impact on mothers and children living in
the intervention clusters, even if the mother was not de-
pressed prenatally? The community intervention was
originally designed to improve outcomes among de-
pressed women. However, we suspect that its design
may lead to broader, population-wide effects.
By working in a rural setting in Pakistan and by
combining the cohorts of perinatally depressed
mothers in the c-RCT and nonperinatally depressed
mothers, the THPP+ study offers a unique opportun-
ity to understand, and to potentially help to mitigate,
the effects of perinatal depression on both the mother
and the child.
Trial status
The THPP trial (and hence the THPP+ trial) began re-
cruitment of participants in October 2014. Based on our
previous work and pilot results with an approximately
25% rate of perinatal depression, we expect to recruit
the sample by the end of February 2016. The endpoint
assessments of all the participants at 36 postnatal
months will be completed by end 2018.
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